Corporate ActionJun 5, 2026, 04:37 PM
Plus Therapeutics to Sell Up to $17.35M Common Stock via ATM Offering
AI Summary
Plus Therapeutics, Inc. has entered into an Equity Distribution Agreement with Canaccord Genuity LLC, enabling the company to sell up to $17,350,000 of its common stock. The shares will be offered "at the market" on the Nasdaq Capital Market, with the agent receiving a 3.0% commission. The net proceeds from this offering are intended to be used for general corporate purposes and working capital.
Key Highlights
- Plus Therapeutics entered an Equity Distribution Agreement on June 1, 2026.
- The company may sell up to $17,350,000 of common stock.
- Sales will be conducted as an "at the market offering" on Nasdaq Capital Market.
- Canaccord Genuity LLC will act as agent, receiving a 3.0% commission.
- The company will reimburse the agent $75,000 for expenses.
- Net proceeds are designated for general corporate purposes and working capital.
- The offering is pursuant to a Form S-3 Registration Statement filed June 2, 2026.
Price Impact
More from PSTV